WASHINGTON (Reuters) - Supreme Court justices on Monday signaled uncertainty over how they would rule on whether brand-name drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off the market.
via Reuters: Health News Read More Here..
No comments:
Post a Comment